Psychotherapy works, and it works well for most people. Across large analyses of clinical trials, therapy produces a medium-to-large effect on symptoms compared to no treatment, with a pooled effect size of 0.72 for depression alone. In practical terms, that means the average person who completes therapy ends up better off than roughly 76% of people who don’t receive it. But effectiveness varies by condition, type of therapy, and individual factors, so the fuller picture is worth understanding.
What the Numbers Actually Mean
Researchers measure therapy’s impact using effect sizes, which capture how much a treated group improves compared to a control group. For psychotherapy across depression studies, the average effect size is 0.56 to 0.72, which falls in the medium-to-large range. To put that in perspective, this is comparable to or better than many widely accepted medical treatments. It doesn’t mean therapy works for everyone, but it means that across thousands of patients in controlled trials, the benefit is consistent and meaningful.
For specific conditions, the numbers get more concrete. In a 10-year follow-up study of older adults with anxiety and depression, 58% of those who received cognitive behavioral therapy (CBT) achieved full remission of all their diagnoses, compared to 27% in a comparison group. For depressive disorders specifically, 88% of the CBT group remitted versus 54% of controls. For anxiety disorders, it was 63% versus 35%. These are long-term results, not just short-term relief.
How Different Therapy Types Compare
CBT is the most studied form of psychotherapy and consistently shows strong results for depression, anxiety, insomnia, and PTSD. In head-to-head trials against psychodynamic therapy (the approach rooted in exploring unconscious patterns and past experiences), CBT tends to produce larger improvements in symptom severity, quality of life, and interpersonal problems. One randomized trial of 147 patients with common mental health conditions found that the CBT group had significantly better outcomes across all three of those measures six months after treatment ended.
That said, psychodynamic therapy still outperforms no treatment, and some people respond better to the exploratory, relationship-focused style it offers. The “best” therapy depends partly on the condition and partly on what resonates with you.
For borderline personality disorder, dialectical behavior therapy (DBT) stands out. In controlled trials, DBT significantly reduced self-harm, depression, anxiety, and hospitalization frequency compared to standard community treatment. Patients in DBT programs improved on 10 of 11 measures of psychological functioning and showed significantly greater gains than waitlist controls on seven of nine variables, including social adjustment and global mental health.
Session Frequency Matters More Than Session Count
One of the more surprising findings in recent research is that the total number of therapy sessions doesn’t predict how much you’ll improve. A meta-analysis of depression treatments found no relationship between the number of sessions and the size of the treatment effect. Total contact time between therapist and client didn’t matter either.
What did matter was frequency. Increasing from one session per week to two was associated with a dramatically larger effect size, an increase of 0.596. Longer treatment durations actually showed a slight negative association with outcomes, with each additional week linked to a small decrease in effect. This suggests that consistent, frequent engagement early in treatment may be more valuable than stretching therapy over many months at a lower frequency. If you’re starting therapy and have the option, twice-weekly sessions could accelerate your progress.
Therapy vs. Medication for Long-Term Results
For depression, psychotherapy and antidepressant medication produce similar results in the short term. Where therapy pulls ahead is after treatment ends. Multiple large reviews have found that people who complete CBT have a significantly lower risk of relapse compared to those treated with medication alone. This advantage is recognized across international clinical guidelines, including those from the American College of Physicians and the UK’s National Institute for Health and Care Excellence.
The likely reason is that therapy teaches skills. Medication changes brain chemistry while you take it, but therapy changes how you process thoughts, handle stress, and respond to setbacks. Those skills persist after the last session. For many people, the ideal approach is a combination of both, particularly for moderate-to-severe depression, but if you’re choosing one path for long-term stability, therapy has a meaningful edge in preventing relapse.
When Depression Hasn’t Responded to Treatment
For people whose depression hasn’t improved after trying multiple medications, the picture is less clear. The large STAR*D trial found that switching to cognitive therapy or adding it to medication produced remission rates of 23 to 25%, which were not significantly different from switching to or adding another medication (28 to 33%). Other controlled trials comparing therapy to medication augmentation strategies in treatment-resistant depression have mostly found no significant differences between approaches.
This doesn’t mean therapy is useless for treatment-resistant depression. One small trial of DBT in this population found large improvements in depression scores compared to a waitlist. But the overall evidence base is thin, and no single approach, whether therapy or medication, has proven clearly superior for people in this difficult situation.
The Therapist Relationship Is a Consistent Predictor
Regardless of which type of therapy you choose, the quality of the relationship between you and your therapist predicts about 8% of the variability in outcomes. That may sound small, but it’s a remarkably consistent finding across all therapy types, patient populations, and conditions. It means that feeling heard, respected, and understood by your therapist isn’t just a nice bonus. It’s a measurable ingredient in whether therapy works.
If you don’t feel a connection with your therapist after a few sessions, switching is reasonable and supported by the evidence. The specific techniques matter, but so does the person delivering them.
Video Sessions Work Just as Well
A meta-analysis of randomized trials comparing video-based therapy to in-person sessions found no significant difference in outcomes at the end of treatment or at follow-up. The effect sizes were nearly identical. Teletherapy produced large symptom reductions on its own, and dropout rates were the same as in-person therapy. If geography, cost, or scheduling makes in-person sessions difficult, video therapy is not a compromise. It’s an equivalent option.
The Financial Case for Therapy
Beyond symptom relief, therapy reduces overall healthcare spending. An analysis of 19 employer-based studies found that enhanced behavioral health services produced a return on investment of 2.3 to 1, meaning every dollar spent on mental health care saved $2.30 in total medical costs. That translated to annual net savings of about 14% on healthcare spending. The savings came primarily from reduced physical health costs among people with chronic conditions, because treating depression and anxiety improves medication adherence, physical activity, and the biological stress pathways that drive conditions like high blood pressure. At the 1.0 threshold, the therapy program pays for itself entirely. These programs consistently exceeded that.